Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis

NCT03025269 · clinicaltrials.gov ↗

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Ocrelizumab

Sponsor

University at Buffalo